Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jun 23;14:1195864. doi: 10.3389/fphar.2023.1195864

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Tang, Zhang, Fan, Xu, Xiong, Tang, Jiang, Zhang, Zhang, Luo and Xu.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

METABRIC and TCGA risk scores compared with AUCs during 1–5 years of clinical characteristics (A, B); ROC curve of risk score of GSE91061 dataset (C); ROC curve of TIDE predicted immunotherapy response in data set GSE91061 (D); ROC curve of risk score and TIDE effect on immunotherapy in dataset GSE91061 (E); ROC curve of risk score of GSE135222 dataset (F); ROC curve of TIDE predicted immunotherapy response in data set GSE135222 (G); ROC curve of risk score and TIDE response to immunotherapy in dataset GSE135222 (H); ROC curve of risk score of data set IMvigor210 (I); ROC curve of TIDE predicted immunotherapy response in the data set IMvigor210 (J); ROC curve of risk score and TIDE effect on immunotherapy in data set IMvigor210 (K).